Reducing Discomfort in Women with Endometrial Cancer Through Ultrasound Imaging

Recruiting · Endometrial Cancer · New Jersey and New York

Check if I qualify View on ClinicalTrials.gov

About this trial

This study looks at how well multiparametric ultrasound (mpUS) can assess vaginal tissue in women undergoing a specific treatment called intravaginal brachytherapy (IVRT) for endometrial cancer. IVRT is a common treatment, but it may cause some changes or discomfort in the vaginal area. Researchers want to see if mpUS imaging can help understand these effects better and if participants can tolerate the imaging process.

The trial's ID number is NCT07318415. It is not FDA-regulated and aims to include around 10 participants.

Who can join

Women aged 18 and older with a diagnosis of endometrial cancer can join. They should have had specific surgeries and be able to start radiotherapy within 12 weeks after surgery. Women cannot participate if they are receiving chemotherapy, have certain other health issues, or have had prior pelvic radiotherapy.

Condition

Endometrial Cancer

Age group

Adult, Older adult

Sex

Female

The study team makes the final call on eligibility.

What happens in the study

All participants will receive standard IVRT and undergo mpUS imaging at several points: before treatment, right after treatment, and at 3, 6, and 12 months after treatment. They will also complete a questionnaire about their vaginal health.